glp 1 for anti inflammatory GLP-1 Agonists in Cardiovascular Diseases: Mechanisms, Clinical Evidence, and Emerging Therapies Health Feed - Glp-1 Drugs
Description
Healthcare providers must weigh the risks and benefits of prescribing GLP-1 agonists, DPP-4 inhibitors, and SGLT2 inhibitors to patients with pancreatitis, particularly those with a history of pancreatic disorders
Who tells them they have a bespoke solution which can unlock an extra 10 years, who claims to have produced a new molecule that will reverse skin and cellular aging, who holds the longevity pill
This article aims to break down the benefits, side effects, clinical data, and real-world considerations that surround GLP-1 therapies, helping you make informed decisions about their place in modern diabetes care
Thyroid-Related Concerns : Although primarily observed in rodent studies, tirzepatide carries a boxed warning regarding thyroid C-cell tumors
